Hospital
Einstein Medical Center Montgomery
Einstein Medical Center Montgomery was paid $7.47M by Medicaid between Jan 2019 and Dec 2024, across 169 billing codes. Its largest line is G0378, Hospital observation service, per hour — 32% of everything it billed.
33Billing provider infoEINSTEIN MEDICAL CENTER MONTGOMERY
EAST NORRITON, PA 19403
EAST NORRITON, PA 19403
33aNPI1104192590assigned 03/29/2012
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.47M
24GClaims102,617
24DCodes billed169
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#43 of 154
Median peer was paid$2.82M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,681 | $79K | |
| 2020 | 19,345 | $1.06M | |
| 2021 | 50,942 | $3.88M | |
| 2022 | 7,376 | $928K | |
| 2023 | 12,129 | $991K | |
| 2024incomplete | 11,144 | $529K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 32% | 1,676 | 1,462 | $2.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 8,290 | 7,838 | $1.55M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 4,586 | 4,396 | $960K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 2,871 | 2,719 | $498K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.3% | 1,263 | 1,194 | $244K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.4% | 2,864 | 2,662 | $176K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 723 | 700 | $141K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.5% | 72 | 70 | $112K |
| S5000 | Prescription drug, generic | 1.3% | 11,174 | 4,479 | $97K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 83 | 77 | $90K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 774 | 765 | $86K |
| 62323 | 1.1% | 131 | 125 | $82K |
157 more codes
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 1,092 | $67K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 473 | $66K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 653 | $47K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 135 | $47K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 465 | $45K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 780 | $45K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 381 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,662 | $34K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 383 | $30K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 146 | $29K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,676 | $27K |
| 76801 | <1% | 451 | $27K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 182 | $26K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,296 | $26K |
| 76830 | Ultrasound, transvaginal | <1% | 421 | $23K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 774 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 512 | $21K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 273 | $20K |
| 59025 | Fetal non-stress test | <1% | 1,504 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 2,987 | $20K |
| 76813 | <1% | 262 | $20K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 228 | $17K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 52 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 228 | $15K |
| 76642 | <1% | 202 | $12K | |
| 76536 | <1% | 161 | $11K | |
| 77066 | Tomosynthesis, mammo | <1% | 93 | $9K |
| 71250 | <1% | 144 | $9K | |
| 72141 | <1% | 28 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,317 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 399 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 884 | $8K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 149 | $7K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 100 | $7K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 214 | $7K |
| 73564 | <1% | 286 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 27 | $6K |
| 85027 | <1% | 1,412 | $6K | |
| 77065 | Tomosynthesis, mammo | <1% | 72 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 655 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,003 | $6K |
| 73030 | <1% | 310 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 494 | $5K |
| 83880 | <1% | 215 | $5K | |
| 95886 | <1% | 75 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 278 | $3K |
| 73610 | <1% | 177 | $3K | |
| 77080 | <1% | 48 | $3K | |
| 72110 | <1% | 113 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 30 | $3K |
| 73630 | <1% | 253 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 27 | $3K |
| 93971 | <1% | 80 | $3K | |
| 82248 | <1% | 1,056 | $3K | |
| 76770 | <1% | 47 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 249 | $3K |
| 86850 | <1% | 326 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 758 | $3K |
| 73130 | <1% | 217 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 309 | $3K |
| 96367 | <1% | 57 | $2K | |
| 83735 | <1% | 1,712 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $2K |
| 72114 | <1% | 77 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 575 | $2K |
| Q3014 | Telehealth originating site facility fee | <1% | 148 | $2K |
| 84484 | <1% | 1,072 | $2K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 12 | $2K |
| J3490 | Unclassified drugs | <1% | 787 | $2K |
| 84100 | <1% | 1,583 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 404 | $2K |
| 73110 | <1% | 115 | $1K | |
| 73502 | <1% | 64 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 85 | $1K |
| 77062 | <1% | 38 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 861 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 352 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 842 | $1K |
| 85610 | <1% | 754 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 217 | $1K |
| 85730 | <1% | 506 | $1K | |
| 84702 | <1% | 102 | $994.26 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 775 | $983.71 |
| 86900 | <1% | 422 | $982.28 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 13 | $945.29 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 326 | $912.50 |
| 96376 | <1% | 271 | $896.22 | |
| 70496 | <1% | 12 | $887.04 | |
| 72040 | <1% | 47 | $882.39 | |
| 83690 | <1% | 769 | $862.69 | |
| 81001 | <1% | 785 | $789.61 | |
| C1769 | Guide wire | <1% | 70 | $767.93 |
| 81003 | <1% | 749 | $702.86 | |
| 73562 | <1% | 33 | $653.57 | |
| 76820 | <1% | 22 | $649.17 | |
| 76775 | <1% | 16 | $609.31 | |
| 99241 | <1% | 12 | $591.10 | |
| 86901 | <1% | 366 | $589.85 | |
| 82962 | <1% | 1,174 | $587.10 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 46 | $560.04 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 266 | $443.90 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,639 | $430.11 |
| 84703 | <1% | 166 | $422.21 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 22 | $419.80 |
| 76000 | <1% | 26 | $367.06 | |
| 83605 | <1% | 271 | $355.44 | |
| 82247 | <1% | 35 | $350.72 | |
| 77061 | <1% | 13 | $341.14 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $312.40 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,126 | $305.18 |
| 82728 | <1% | 49 | $299.17 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 38 | $287.38 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 12 | $285.26 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 30 | $283.22 |
| 73560 | <1% | 24 | $246.95 | |
| 80061 | Lipid panel | <1% | 68 | $246.82 |
| 72100 | <1% | 14 | $241.16 | |
| 83540 | <1% | 52 | $199.07 | |
| 81025 | <1% | 870 | $192.74 | |
| 74018 | <1% | 16 | $189.88 | |
| 82607 | <1% | 46 | $172.97 | |
| 80320 | <1% | 64 | $169.85 | |
| 73080 | <1% | 16 | $157.60 | |
| 72020 | <1% | 22 | $157.40 | |
| 73590 | <1% | 13 | $152.32 | |
| 88342 | <1% | 25 | $146.60 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 265 | $136.30 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 512 | $120.97 |
| 83550 | <1% | 41 | $105.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,540 | $100.56 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 657 | $91.76 |
| 82746 | <1% | 16 | $74.02 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,308 | $62.74 |
| 87205 | <1% | 44 | $59.88 | |
| 87186 | <1% | 29 | $58.96 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 233 | $41.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,808 | $39.61 |
| 82550 | <1% | 38 | $35.95 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 302 | $35.64 |
| 87070 | <1% | 15 | $32.10 | |
| 87040 | <1% | 15 | $28.00 | |
| 85652 | <1% | 25 | $25.51 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,311 | $20.86 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 29 | $17.50 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 81 | $15.34 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 277 | $6.33 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 46 | $1.21 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 167 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 32 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 90 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 16 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 171 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 38 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 446 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 38 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWYATT, WALTER (ASSOCIATE VICE PRESIDENT - FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Einstein Medical Center Montgomery | East Norriton, PA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.